Astronaut Calls Rocks Mammals- Houston Asks Are There Any Disney Cat or Dog Rocks in The Nevada Fake Moon Bay.
This video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Geology Station 5 at Camelot Crater
Journal Text: 146:30:19
ALL NASA FOOTAGE USED IN THIS FILM IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
The Investor Desk Presents US Highland, Inc. (OTC PINK: UHLN), a diversified product development, sales, and marketing company.
Since its founding in 1997 as Highland AB in Sweden, the Texas-based company has been developing and manufacturing high-performance single cylinder and V-twin powertrains used for a variety of applications. In September 2015, the publicly traded company began diversifying its operations, guiding startups in the marketing, reselling, and distributing of their products, as well as helping customers establish their brand and penetrate the U.S. market.
Overseeing the company’s growth is chief executive officer and president Josh Whitaker, a marketing executive with global experience in technology marketing, strategy, and implementation. Whitaker has worked with high-profile brands like Red Bull and Under Armour, as well as industry leading companies like Tucker Rocky Distributing and KTM Motorcycles.
Over the past two decades, US Highland, Inc. has tapped a variety of distribution channels, enabling growing businesses, both domestic and foreign, to launch their products in the United States whether wholesale, retail, or over the Internet.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7660851-us-highland-the-investor-desks-new-company/
Moët Hennessy, Official Partner, reaffirms its support for Solar Impulse and its pursuit of the first round-the-world flight powered only by solar energy.
"Celebrating Sustainability"
Its support of Solar Impulse as an Official Partner shows Moët Hennessy's taste for pushing the envelope and conquering new territories, as well as recognizing the role of excellence and innovation as two key drivers of progress worldwide.
Growth in the Moët Hennessy group and its 22 prestigious brands has been powered by their pioneering spirit and the conquest of new territories. The first consignment of champagne was dispatched to Russia in 1780 by Veuve Clicquot. Hennessy began exporting cognac to the United States in 1787, two years before the French Revolution, followed by China in 1859. Today, Moët Hennessy exports 95% of its production and is the world's leading producer and exporter of luxury wines and spirits.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7813551-moet-hennessy-solar-impulse/
Fetzer Vineyards, the historic Mendocino County-based winery lauded for its beloved American wine brands and pioneering leadership in sustainability, is celebrating its 50th anniversary in 2018. The flagship Fetzer brand will honor the 50th anniversary year through a variety of activities, most notably the Fetzer 50th Storyteller Series, a robust social media campaign showcasing video interviews with past and present Fetzer luminaries. Fetzer Vineyards’ golden anniversary comes at an exciting time for the winery, which recently expanded into the luxury wine and spirits space and was recognized by the United Nations with a Momentum for Change award for its pacesetting sustainability practices.
To view the multimedia release go to:
https://www.multivu.com/players/English/8255951-fetzer-vineyards-50-years-storyteller-series/
Neighbors across the country will soon have an exciting opportunity to help change their communities for the better through State Farm Neighborhood Assist®. This philanthropic program awards 40 causes a $25,000 grant. Anyone in the United States can submit a cause beginning March 9 through March 30. Ultimately, voters will decide which community improvement projects win big.
Returning for its fourth year, State Farm Neighborhood Assist asks individuals to identify causes that would help make their communities safer, stronger and better-educated. Up to 4,000 causes will be accepted. The State Farm Youth Advisory Board (YAB) will then narrow down the field, using a scoring rubric to identify the top 200 submissions. The public will have a chance to vote 10 times a day from May 14 through June 3 for their favorite causes from the list of finalists. The 40 causes that receive the most votes will win a $25,000 grant. The nominations and votes will be accepted exclusively through a free Facebook app.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7417331-state-farm-neighborhood-assist/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
The Perelman School of Medicine at the University of Pennsylvania and the March of Dimes Foundation announce the launch of a new $10 million Prematurity Research Center here.
The March of Dimes will invest $10 million during the next five years to create a transdisciplinary center conducting team-based research, led by physicians and researchers at the Hospital of the University of Pennsylvania and The Children’s Hospital of Philadelphia, to discover the unknown causes of preterm birth and develop new strategies to prevent it. This March of Dimes Prematurity Research Center at the University of Pennsylvania is part of a “medical Manhattan Project” of five such centers in the United States created by the foundation since 2011.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
In anticipation of Thomas Edison’s birthday and National Inventors' Day on Feb. 11, the National Inventors Hall of Fame®, in partnership with the United States Patent and Trademark Office (USPTO), announces it will induct 15 innovation pioneers for their world-changing inventions on May 2-3 during The Greatest Celebration of American Innovation.
This year’s Class of Inductees includes innovators such as Ching Wan Tang and Steven Van Slyke (OLED display technology), Stan Honey (football’s “yellow first-and-ten line”), Mary Engle Pennington (food preservation and storage), and Paul Terasaki (tissue typing for organ transplants), just to name a few. To view the full list of 2018 Inductees, visit http://bit.ly/2kAXcrX.
To view the multimedia release go to:
https://www.multivu.com/players/English/8244151-national-inventors-hall-of-fame-15-innovators-2018-class/
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
A new solar power system is installed in the United States every 1.6 minutes, according to the Solar Energy Industries Association (SEIA). With the number of residential solar installations expected to increase this year by 35 percent according to GTM Research, more consumers will have an opportunity to choose the best solar solution for their home, saving on electricity bills while generating clean energy. Offering a record-setting, proven solar power solution, SunPower reminds homeowners that better solar technology exists and is accessible today.
“Solar technology differs widely from brand to brand, so it’s important for consumers to consider that not all panels deliver the same amount of energy, look elegant on a roof, or are guaranteed to last as long as promised,” said Howard Wenger, SunPower president, business units. “SunPower® panels are the most efficient that homeowners can buy, and we stand behind them for a quarter century. We’re proud to hold the world-record title for efficiency.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7706151-sunpower-residential-solar-panel/
